{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:15:08Z","timestamp":1780092908484,"version":"3.54.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of hepatocellular carcinoma (HCC) is increasing worldwide and\u00a0it\u00a0is now\u00a0the third most common cause of cancer-related death. HCC is becoming a major health burden with steadily increasing incidence globally.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is an observational study over a 3-year period in a tertiary care center in India. Three hundred and\u00a0thirty-nine patients diagnosed to have HCC were included in this study. Patients\u2019 clinical, etiological, radiological and cytohistological data and therapy offered were recorded and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cirrhosis of the liver was seen in 73.2% of the patients. 16.8% of patients were asymptomatic at the time of presentation. Ascites (57.2%) and jaundice (22.4%) were the most common signs of hepatic decompensation. The most common etiology of HCC was cryptogenic\/non-alcoholic fatty liver disease (NAFLD) in 51% of the patients, while hepatitis B and C were seen in 17.4% and 5.8% of the patients, respectively. Advanced\u00a0and end-stage disease with Barcelona Clinic Liver Cancer (BCLC) stages\u00a0C and D were seen in 62.4% of patients. 56.6% had Albumin-bilirubin (ALBI) score of 2, while 62.8% had Okuda stage II disease. High alpha-fetoprotein (AFP) levels (&gt;400 ng\/mL) were seen in 48.9% of patients. Macrovascular invasion and metastases were seen in 45.9% and 22.2% of the patients, respectively. 17.6% of patients had evidence of tumor thrombus. 14.5% of biopsy specimens showed associated steatosis\/steatohepatitis along with confirmation of HCC. Only 26.6% of the cirrhotic HCC patients were diagnosed during surveillance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HCC due to unknown cause\/NAFLD appears to be overtaking hepatitis B as the commonest cause for HCC. Despite the advances in diagnostic methods and surveillance, most cases of HCC tend to be diagnosed at advanced stages.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12664-021-01209-0","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T15:13:09Z","timestamp":1646061189000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2070-9140","authenticated-orcid":false,"given":"Balaji","family":"Musunuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Udupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"1209_CR1","doi-asserted-by":"crossref","unstructured":"Younossi Z, Stepanova M, Ong JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17:748\u201355.","DOI":"10.1016\/j.cgh.2018.05.057"},{"key":"1209_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.\u00a0","DOI":"10.3322\/caac.21492"},{"key":"1209_CR3","doi-asserted-by":"crossref","unstructured":"Kumar A, Acharya SK, Singh SP, et al. 2019 Update of Indian National Association for study of the liver consensus on prevention, diagnosis, and management of hepatocellular carcinoma in India: The Puri II Recommendations. J Clin Exp Hepatol. 2020;10:43\u201380.","DOI":"10.1016\/j.jceh.2019.09.007"},{"key":"1209_CR4","doi-asserted-by":"crossref","unstructured":"Acharya SK. Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014;4 Suppl 3:S27\u201333.","DOI":"10.1016\/j.jceh.2014.05.013"},{"key":"1209_CR5","unstructured":"Paul SB, Gulati MS, Madan K, et al. Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India. Indian J Gastroenterol. 2007;26:274\u20138."},{"key":"1209_CR6","doi-asserted-by":"crossref","unstructured":"EASL. Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"1209_CR7","doi-asserted-by":"crossref","unstructured":"Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology. 1996;23:1025\u20139.","DOI":"10.1002\/hep.510230513"},{"key":"1209_CR8","doi-asserted-by":"crossref","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464\u201370.","DOI":"10.1053\/jhep.2001.22172"},{"key":"1209_CR9","doi-asserted-by":"crossref","unstructured":"Elsayes KM, Hooker JC, Agrons MM, et al. 2017 Version of LI-RADS for CT and MR imaging: An update. Radiographics. 2017;37:1994-2017.\u00a0","DOI":"10.1148\/rg.2017170098"},{"key":"1209_CR10","doi-asserted-by":"crossref","unstructured":"Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329\u201338.","DOI":"10.1055\/s-2007-1007122"},{"key":"1209_CR11","doi-asserted-by":"crossref","unstructured":"Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918\u201328.","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E"},{"key":"1209_CR12","doi-asserted-by":"crossref","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550\u20138.","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"1209_CR13","doi-asserted-by":"crossref","unstructured":"Sangiovanni A, Prati GM, Fasani P, et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology. 2006;43:1303\u201310.","DOI":"10.1002\/hep.21176"},{"key":"1209_CR14","doi-asserted-by":"crossref","unstructured":"Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM. 2008;101:479-85.\u00a0","DOI":"10.1093\/qjmed\/hcn033"},{"key":"1209_CR15","doi-asserted-by":"crossref","unstructured":"Paul SB, Chalamalasetty SB, Vishnubhatla S, et al. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology. 2009;77:162\u201371.","DOI":"10.1159\/000231886"},{"key":"1209_CR16","doi-asserted-by":"crossref","unstructured":"Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3\u201316.","DOI":"10.1055\/s-0030-1247128"},{"key":"1209_CR17","doi-asserted-by":"crossref","unstructured":"Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of hepatocellular carcinoma in the Asia-Pacific Region. Gut Liver. 2016;10:332\u20139.","DOI":"10.5009\/gnl15257"},{"key":"1209_CR18","doi-asserted-by":"crossref","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264\u201373.","DOI":"10.1053\/j.gastro.2011.12.061"},{"key":"1209_CR19","doi-asserted-by":"crossref","unstructured":"Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis. 2010;42:341-7.\u00a0","DOI":"10.1016\/j.dld.2009.09.002"},{"key":"1209_CR20","doi-asserted-by":"crossref","unstructured":"Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007;22:1104\u201311.","DOI":"10.1111\/j.1440-1746.2007.04908.x"},{"key":"1209_CR21","doi-asserted-by":"crossref","unstructured":"Saini N, Bhagat A, Sharma S, Duseja A, Chawla Y. Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center. Clin Chim Acta. 2006;371:183-6.","DOI":"10.1016\/j.cca.2006.02.038"},{"key":"1209_CR22","doi-asserted-by":"crossref","unstructured":"Sarin SK, Thakur V, Guptan RC, et al. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol. 2001;16:666\u201373.","DOI":"10.1046\/j.1440-1746.2001.02476.x"},{"key":"1209_CR23","doi-asserted-by":"crossref","unstructured":"Sood A, Midha V, Goyal O, Goyal P, Sood N, Sharma SK. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India. Indian J Gastroenterol. 2014;33:35-40.","DOI":"10.1007\/s12664-013-0373-7"},{"key":"1209_CR24","doi-asserted-by":"crossref","unstructured":"Srirambhatla J, Linga VG, Kalpathi KM, et al. Current profile of hepatocellular carcinoma from a tertiary care center in Andhra Pradesh. Indian J Gastroenterol. 2015;34:335\u20136.","DOI":"10.1007\/s12664-015-0590-3"},{"key":"1209_CR25","doi-asserted-by":"crossref","unstructured":"Pal S, Ramachandran J, Kurien RT, et al. Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South India. Trop Doct. 2013;43:25-6.","DOI":"10.1177\/0049475512473600"},{"key":"1209_CR26","doi-asserted-by":"crossref","unstructured":"Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155:323\u201331.","DOI":"10.1093\/aje\/155.4.323"},{"key":"1209_CR27","doi-asserted-by":"crossref","unstructured":"Qadan M, Kothary N, Sangro B, Palta M. The treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Am Soc Clin Oncol Educ Book. 2020;40:1-8.\u00a0","DOI":"10.1200\/EDBK_280811"},{"key":"1209_CR28","doi-asserted-by":"crossref","unstructured":"Zheng J, Cai J, Li H, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review. Cell Physiol Biochem. 2017;44:967\u201381.","DOI":"10.1159\/000485396"},{"key":"1209_CR29","doi-asserted-by":"crossref","unstructured":"Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010;26:2183\u201391.","DOI":"10.1185\/03007995.2010.506375"},{"key":"1209_CR30","doi-asserted-by":"crossref","unstructured":"Singal AG, Yopp AC, Gupta S, et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res. 2012;5:1124\u201330.","DOI":"10.1158\/1940-6207.CAPR-12-0046"},{"key":"1209_CR31","doi-asserted-by":"crossref","unstructured":"Vergara V, Muratore A, Bouzari H, et al. Spontaneous rupture of hepatocelluar carcinoma: surgical resection and long-term survival. Eur J Surg Oncol. 2000;26:770\u20132.","DOI":"10.1053\/ejso.2000.1001"},{"key":"1209_CR32","doi-asserted-by":"crossref","unstructured":"Zhu Q, Li J, Yan JJ, Huang L, Wu MC, Yan YQ. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma. World J Gastroenterol. 2012;18:7302-7.","DOI":"10.3748\/wjg.v18.i48.7302"},{"key":"1209_CR33","doi-asserted-by":"crossref","unstructured":"David D, Raghavendran A, Goel A, et al. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India. Indian J Gastroenterol. 2017;36:373\u20139.","DOI":"10.1007\/s12664-017-0785-x"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-021-01209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-021-01209-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-021-01209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T01:15:10Z","timestamp":1652663710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-021-01209-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1007\/s12664-021-01209-0","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BM, SS, GB, KU, and AP\u00a0declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer\/publishers are responsible for the results\/findings and content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}